Saturday, March 18, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biosecurity

Court Rules FDA Must Reconsider Petitions for Antibiotic Ban

by Global Biodefense Staff
June 8, 2012

A federal judge ruled this week that the FDA must reconsider previously denied petitions to ban the use of certain medically important antibiotics used in animal agriculture.

The order comes just a few days after the FDA issued a notice it will appeal a magistrate judge’s March ruling, which found that the agency unlawfully failed to act on its own 1977 proposal to ban penicillin and two types of tetracycline from animal feed despite evidence of a public health risk.

As part of its defense, the FDA has pointed to its new voluntary guidance promoting the judicious use of antibiotics in food animal production…

Read the full story at Food Safety News

Tags: Agro-DefenseAntimicrobialsFood Safety

Related Posts

DARPA Pursues Advanced Threat-Detection for Crop Defense
Biosecurity

DARPA Pursues Advanced Threat-Detection for Crop Defense

January 3, 2023
Much of the CDC is Working Remotely. That Could Make Changing the Agency Difficult.
Policy + Initiatives

Much of the CDC is Working Remotely. That Could Make Changing the Agency Difficult.

December 7, 2022
Study: Cash Incentives and Lotteries Do Little to Increase Adult Vaccinations
Medical Countermeasures

Study: Cash Incentives and Lotteries Do Little to Increase Adult Vaccinations

October 25, 2022
Black Veterans Hospitalized with COVID-19 Less Likely to Receive Treatments Than White Veterans
Public Health

Black Veterans Hospitalized with COVID-19 Less Likely to Receive Treatments Than White Veterans

October 25, 2022
Load More

Latest News

Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC